Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending March 24
Ally Financial, NFL, Papa Johns, Overair, LastPass, Curbio, Hinge Health, Momnt, Sealed Air, Infobip
By
Lauren Muskett
| March 24, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Humira
M&A
Botox Maker Allergan Sold to AbbVie for $63B
AbbVie faces pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces increased competition from cheaper versions in Europe.
By
Lauren Muskett
| June 25, 2019
Read More
Tax
Treasury Stance Regardless, Another Tax-Inversion Deal Pops Up
AbbVie's plans to pay less taxes by relocating to Britain after buying Shire touches a raw nerve in Washington.
By
Iris Dorbian
| July 19, 2014
Read More